TE_37639
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | HERVH |
---|---|
TE superfamily | ERV1 |
TE class | LTR |
Gene | TLR8-AS1, - |
Class | Chimeric, Intergenic |
Coding | Non-coding |
Tumor-specific score | 261.49 |
Counts of samples | TCGA_tumor:231; TCGA_normal:0; GTEx:0 |
TSS | chrX(-):12943716 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_37639.1 | TLR8-AS1 | Chimeric | Non-coding | Non-coding | chrX(-):12903965,12903985,12906190,12906251,12910548,12910802,12942218,12942334,12943585,12943717 |
teRNA_37639.2 | TLR8-AS1 | Chimeric | Non-coding | Non-coding | chrX(-):12903965,12903985,12906190,12906251,12910675,12910802,12942218,12942334,12943585,12943717 |
teRNA_37639.3 | TLR8-AS1 | Chimeric | Non-coding | Non-coding | chrX(-):12903965,12903985,12906190,12906251,12908216,12908333,12910675,12910802,12942218,12942334,12943585,12943717 |
teRNA_37639.4 | TLR8-AS1 | Chimeric | Non-coding | Non-coding | chrX(-):12903965,12903985,12906190,12906251,12942218,12942334,12943585,12943717 |
teRNA_37639.5 | TLR8-AS1 | Chimeric | Non-coding | Non-coding | chrX(-):12903965,12903985,12906190,12906251,12908216,12908333,12942218,12942334,12943585,12943717 |
teRNA_37639.6 | TLR8-AS1 | Chimeric | Non-coding | Non-coding | chrX(-):12903965,12903985,12906190,12906251,12908216,12908333,12910548,12910802,12942218,12942334,12943585,12943717 |
teRNA_37639.7 | - | Intergenic | Non-coding | Non-coding | chrX(-):12921436,12921456,12942218,12942334,12943585,12943717 |
teRNA_37639.8 | - | Intergenic | Non-coding | Non-coding | chrX(-):12798410,12798430,12809228,12809349,12824398,12824470,12942218,12942334,12943585,12943717 |
teRNA_37639.9 | - | Intergenic | Non-coding | Non-coding | chrX(-):12817145,12817165,12824398,12824470,12942218,12942334,12943585,12943717 |
teRNA_37639.10 | - | Intergenic | Non-coding | Non-coding | chrX(-):12881179,12881199,12942218,12942334,12943585,12943717 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.